Please login to the form below

Not currently logged in
Email:
Password:

cancer drug funding

This page shows the latest cancer drug funding news and features for those working in and with pharma, biotech and healthcare.

NICE backs CDF funding for Sanofi/Regeneron’s skin cancer drug Libtayo

NICE backs CDF funding for Sanofi/Regeneron’s skin cancer drug Libtayo

Acknowledges unmet need. Patients with a form of skin cancer will be able to access Sanofi/Regeneron's new checkpoint inhibitor Libtayo via the NHS in England, after funding for the ... The cost-effectiveness watchdog has published guidance recommending

Latest news

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Latest Intelligence

  • Engaging the digital healthcare professional Engaging the digital healthcare professional

    When NICE, the UK policymaker for health spending, rejected Pfizer’s breast cancer drug palbociclib for routine funding on the NHS in February, it tweeted the news and invited comments on ... It was also shared by a student midwife who tweeted to

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
SEVEN STONES

Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....

Latest intelligence

AI and genomics: a revolution in drug discovery and development
...
Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....

Infographics